Calyx and Qynapse Announce Partnership


Calyx announced it has entered into a partnership with Qynapse. The partnership enables Calyx to adopt and deliver Qynapse's AI-powered neuroimaging analysis solutions, QyScore® and QyPredict® to its global pharmaceutical and biotech customers as they develop new medical treatments for central nervous system (CNS) disorders.

Read more about the partnership here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.